Join me on my journey across the clinical trial landscape. I will be accompanied by a variety of people, all experts within their field, as we seek to understand and uncover unknowns, to shape ideas, inspire innovation and ultimately to find out how we can truly move clinical trials out of the spiralling void of higher costs and lower outputs. Click on an episode below to listen.
EPISODE 15: WITH BRAD HIGHTOWER
Brad Hightower joins Liam on this week’s podcast episode. Brad is the CEO and founder of Hightower Clinical and the host of Note to File, a clinical trial podcast. Hightower Clinical is an integrated clinical trials company that works directly with physicians to unlock patients at site. In this session we discuss the ups and downs of operating trials at site, how the DCT movement is changing the landscape, how integrated care and research serves the patient and much more.
CEO, HIGHTOWER CLINICAL
Brad Hightower joins Liam on this week’s podcast episode. Brad is the CEO and founder of Hightower Clinical and the host of Note to File, a clinical trial podcast. Hightower Clinical is an integrated clinical trials company that works directly with physicians to unlock patients at site. In this session we discuss the ups and downs of operating trials at site, how the DCT movement is changing the landscape, how integrated care and research serves the patient and much more.
EPISODE 14: WITH LIZ BEATTY
Liz Beatty joins Liam on this week’s podcast episode. Liz is the Chief Strategy Officer at Inato. Inato is a clinical trial marketplace that aims to create greater engagement across a more diverse population of doctors and patients. In this session we discuss a number of trends relating to sites, such as diversity, operating in a digital world, how the sites need a voice in clinical research and much more. We also explore some of the lessons Liz has learned over the years in a variety of different operational roles.
CHIEF STRATEGY OFFICER, INATO
Liz Beatty joins Liam on this week’s podcast episode. Liz is the Chief Strategy Officer at Inato. Inato is a clinical trial marketplace that aims to create greater engagement across a more diverse population of doctors and patients. In this session we discuss a number of trends relating to sites, such as diversity, operating in a digital world, how the sites need a voice in clinical research and much more. We also explore some of the lessons Liz has learned over the years in a variety of different operational roles.
EPISODE 13: WITH KUNAL SAMPAT
Kunal Sampat joins Liam on this week’s podcast episode. Kunal is a clinical coach & host of The Clinical Trial Podcast, he is also the director of operations at Ceribell, Inc. Kunal has a special interest in working with key opinion leaders and sites to boost recruitment in clinical trials. So inevitably we discuss our shared passion of patient recruitment, from different perspectives (both a site and sponsor), understand how sites can leverage workflows to optimise performance and much more.
CLINICAL COACH & HOST AT CLINICAL TRIAL PODCAST
Kunal Sampat joins Liam on this week’s podcast episode. Kunal is a clinical coach & host of The Clinical Trial Podcast, he is also the director of operations at Ceribell, Inc. Kunal has a special interest in working with key opinion leaders and sites to boost recruitment in clinical trials. So inevitably we discuss our shared passion of patient recruitment, from different perspectives (both a site and sponsor), understand how sites can leverage workflows to optimise performance and much more.
EPISODE 12: WITH DAN HYDES AND RICHARD YEATMAN
Dan Hydes and Richard Yeatman join Liam on this week’s podcast episode. Dan (CEO) and Richard (CTO) are the co-founders of Ignite Data. Ignite Data is technology platform that reduces the burden of monitoring and source data verification. In our discussion we discuss the pains of monitoring and source data verification. Understand the barriers and impact it has on trials and most importantly what can be done to resolve it, plus much more.
IGNITE DATA
Dan Hydes and Richard Yeatman join Liam on this week’s podcast episode. Dan (CEO) and Richard (CTO) are the co-founders of Ignite Data. Ignite Data is technology platform that reduces the burden of monitoring and source data verification. In our discussion we discuss the pains of monitoring and source data verification. Understand the barriers and impact it has on trials and most importantly what can be done to resolve it, plus much more.
EPISODE 11: WITH MUSADDIQ KAHN
Musaddiq Khan joins Liam on this week’s podcast episode. Muz is the Vice President, DCT Solutions at Medable. Medable is a technology platform that enables Sponsors to run Decentralised Clinical Trials. In our discussion we discuss the role of innovation in pharma, talk through how pharma thinks about innovation / digital technologies. Understand what impact tech has on clinical development? Is there a process for innovation? And much more.
VP, DCT SOLUTIONS MEDABLE
Musaddiq Khan joins Liam on this week’s podcast episode. Muz is the Vice President, DCT Solutions at Medable. Medable is a technology platform that enables Sponsors to run Decentralised Clinical Trials. In our discussion we discuss the role of innovation in pharma, talk through how pharma thinks about innovation / digital technologies. Understand what impact tech has on clinical development? Is there a process for innovation? And much more.
EPISODE 10: WITH BRUCE HELLMAN
Bruce Hellman joins Liam on this week’s podcast episode. Bruce is CEO & Co-Founder of uMotif. uMotif is an eClinical data capture platform that patients love to use. The platform has been deployed in over 21 clinical clinical conditions. In our discussion we cover the impact of decentralised clinical trials, the challenges of remote data capture and how to overcome them. Human centred design - what is it? How can we use in the clinical trial space? And much more.
CEO & CO-FOUNDER, UMOTIF
Bruce Hellman joins Liam on this week’s podcast episode. Bruce is CEO & Co-Founder of uMotif. uMotif is an eClinical data capture platform that patients love to use. The platform has been deployed in over 21 clinical clinical conditions. In our discussion we cover the impact of decentralised clinical trials, the challenges of remote data capture and how to overcome them. Human centred design - what is it? How can we use in the clinical trial space? And much more.
EPISODE 9: WITH KEN GETZ
Ken Getz joins Liam on this week’s podcast episode. Ken is the Director, Research Professor at Tufts Center for the Study of Drug Development. He is also a Founder, Chairman/CEO of several ventures that serve clinical research and investor, board member and venture advisor. In our discussion we cover the reasons behind changes in protocol practice over the years. Discuss best practices in protocol development, understand why are protocols becoming so complex and what we do with all that data. We also dive into understanding what the regulators think about the volume of data we are collect, plus much more.
DIRECTOR, RESEARCH PROFESSOR AT TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT
Ken Getz joins Liam on this week’s podcast episode. Ken is the Director, Research Professor at Tufts Center for the Study of Drug Development. He is also a Founder, Chairman/CEO of several ventures that serve clinical research and investor, board member and venture advisor. In our discussion we cover the reasons behind changes in protocol practice over the years. Discuss best practices in protocol development, understand why are protocols becoming so complex and what we do with all that data. We also dive into understanding what the regulators think about the volume of data we are collect, plus much more.
EPISODE 8: WITH CRAIG LIPSET
Craig Lipset joins Liam on this week’s podcast episode. Craig is Co-Chair of DTRA, Advisor, Founder of Clinical Innovation Partners and sits on a number of boards for companies in the Life Science space. Craig is really at the forefront of innovation and has launched a number of industry firsts such as the first fully remote/virtual clinical trial for a new medicine to the first returning of results and data to research participants. In our discussion we cover how and why DTRA was formed, what are the best use cases for decentralised trials, the biggest changes faced when running them and how to overcome them and much more.
CO-CHAIR, DECENTRALIZED TRIALS & RESEARCH ALLIANCE (DTRA)
Craig Lipset joins Liam on this week’s podcast episode. Craig is Co-Chair of DTRA, Advisor, Founder of Clinical Innovation Partners and sits on a number of boards for companies in the Life Science space. Craig is really at the forefront of innovation and has launched a number of industry firsts such as the first fully remote/virtual clinical trial for a new medicine to the first returning of results and data to research participants. In our discussion we cover how and why DTRA was formed, what are the best use cases for decentralised trials, the biggest changes faced when running them and how to overcome them and much more.
EPISODE 7: WITH MICHAEL CASEY
Michael Casey joins Liam on this week’s podcast episode. Michael is Executive Director at hyperCORE International and a highly sought-after magician! Michael has had the fortunate position to work across Pharma, CRO and at site, giving him a unique way of thinking! In this session, we chat about hyperCORE and Michael’s background, explore the differing viewpoints and insights of Pharma, CRO and site, talk about the disrupter mindset, understand how data helps decision making and we also get a little philosophical and meta!
EXECUTIVE DIRECTOR, HYPERCORE INTERNATIONAL
Michael Casey joins Liam on this week’s podcast episode. Michael is Executive Director at hyperCORE International and a highly sought-after magician! Michael has had the fortunate position to work across Pharma, CRO and at site, giving him a unique way of thinking! In this session, we chat about hyperCORE and Michael’s background, explore the differing viewpoints and insights of Pharma, CRO and site, talk about the disrupter mindset, understand how data helps decision making and we also get a little philosophical and meta!
EPISODE 6: WITH FEMIDA GWADRY-SRIDHAR
Femida Gwadry-Sridhar joins Liam on this weeks podcast episode. Femida is the CEO and Founder of Pulse Infoframe. In this session we explore all things in the real world evidence space! What is it? How is it used? Where is it used? What lessons can we carry over to other therapy areas? And much more.
CEO & FOUNDER, PULSE INFOFRAME
Femida Gwadry-Sridhar joins Liam on this weeks podcast episode. Femida is the CEO and Founder of Pulse Infoframe. In this session we explore all things in the real world evidence space! What is it? How is it used? Where is it used? What lessons can we carry over to other therapy areas? And much more.
EPISODE 5: WITH KARRI VENN
Karri Venn joins Liam on this weeks podcast episode. Karri is the President of Research at LMC Manna Research and the CEO of hyperCORE International. In this session we explore site operations, take a look at the impact decentralised trials have on sites and how to optimise for these changing times, and of course jump head first into site pain points and more importantly how to overcome them.
PRESIDENT OF RESEARCH, LMC MANNA RESEARCH & CEO OF HYPERCORE
Karri Venn joins Liam on this weeks podcast episode. Karri is the President of Research at LMC Manna Research and the CEO of hyperCORE International. In this session we explore site operations, take a look at the impact decentralised trials have on sites and how to optimise for these changing times, and of course jump head first into site pain points and more importantly how to overcome them.
EPISODE 4: WITH EARL SELTZER
This week Liam talks to Dr Andrew Catchpole about COVID-19, virology research and the world’s first SARS-COV-2 (COVID-19) human challenge model. Dr Catchpole is the Chief Scientific Officer at hVIVO, an industry leading services provider in viral challenge studies that supports product development for companies developing antiviral, vaccines and respiratory therapeutics.
Senior Director, Feasibility and Site Selection, Covance
Earl Seltzer joins Liam on the podcast this episode. Earl is the Senior Director, Feasibility and Site Selection at Covance. In this session we dive into understanding what feasibility and site selection is, the process, challenges of global feasibility and understanding the pain points and how to overcome them.
EPISODE 3 WITH: DR PETER SARGENT
This week Liam talks to Dr Andrew Catchpole about COVID-19, virology research and the world’s first SARS-COV-2 (COVID-19) human challenge model. Dr Catchpole is the Chief Scientific Officer at hVIVO, an industry leading services provider in viral challenge studies that supports product development for companies developing antiviral, vaccines and respiratory therapeutics..
Head of BD, NIHR
Dr Peter Sargent joins Liam on the podcast this episode. Dr Sargent is currently Head of BD at NIHR but his Life Science experience covers scientific, operational and commercial. In this episode we find out what the NIHR is and how it supports Life Science organisations, we also explore what the UK is doing to speed up research alongside some other innovative research approaches.
EPISODE 2: WITH DR PATRICK SHORT
This week Liam talks to Dr Andrew Catchpole about COVID-19, virology research and the world’s first SARS-COV-2 (COVID-19) human challenge model. Dr Catchpole is the Chief Scientific Officer at hVIVO, an industry leading services provider in viral challenge studies that supports product development for companies developing antiviral, vaccines and respiratory therapeutics.
Founder and CEO, Sano Genetics
This week Liam is joined by Dr Patrick Short. Dr Short is the founder and CEO of Sano Genetics, a company who specialise in at home genetic screening and precision recruitment for companies developing precision therapies. In this session Patrick and Liam discuss at home genetic testing, the role of patient transparency and privacy in clinical trials, precision recruitment and much more.
EPISODE 1: WITH DR ANDREW CATCHPOLE
This week Liam talks to Dr Andrew Catchpole about COVID-19, virology research and the world’s first SARS-COV-2 (COVID-19) human challenge model. Dr Catchpole is the Chief Scientific Officer at hVIVO, an industry leading services provider in viral challenge studies that supports product development for companies developing antiviral, vaccines and respiratory therapeutics.
Chief Scientific Officer, hVIVO
This week Liam talks to Dr Andrew Catchpole about COVID-19, virology research and the world’s first SARS-COV-2 (COVID-19) human challenge model. Dr Catchpole is the Chief Scientific Officer at hVIVO, an industry leading services provider in viral challenge studies that supports product development for companies developing antiviral, vaccines and respiratory therapeutics.
“As an industry we should be working cross functionally and sharing our experiences. If you want to learn about and conduct better clinical trials I highly recommend this podcast. Liam is incredibly knowledgeable about all things clinical trials, and in his interviews he does a great job dissecting the biggest challenges and new trends in the industry.”
Dr Patrick Short